<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33927243</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Dissociation of disease onset, progression and sex differences from androgen receptor levels in a mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>9255</StartPage><MedlinePgn>9255</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9255</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-88415-0</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disorder caused by loss of motor neurons. ALS incidence is skewed towards males with typically earlier age of onset and limb site of onset. The androgen receptor (AR) is the major mediator of androgen effects in the body and is present extensively throughout the central nervous system, including motor neurons. Mutations in the AR gene lead to selective lower motor neuron degeneration in male spinal bulbar muscular atrophy (SBMA) patients, emphasising the importance of AR in maintaining motor neuron health and survival. To evaluate a potential role of AR in onset and progression of ALS, we generated SOD1<sup>G93A</sup> mice with either neural AR deletion or global human AR overexpression. Using a Cre-LoxP conditional gene knockout strategy, we report that neural deletion of AR has minimal impact on the disease course in SOD1<sup>G93A</sup> male mice. This outcome was potentially confounded by the metabolically disrupted Nestin-Cre phenotype, which likely conferred the profound lifespan extension observed in the SOD1<sup>G93A</sup> double transgenic male mice. In addition, overexpression of human AR produced no benefit to disease onset and progression in SOD1<sup>G93A</sup> mice. In conclusion, the disease course of SOD1<sup>G93A</sup> mice is independent of AR expression levels, implicating other mechanisms involved in mediating the sex differences in ALS. Our findings using Nestin-Cre mice, which show an inherent metabolic phenotype, led us to hypothesise that targeting hypermetabolism associated with ALS may be a more potent modulator of disease, than AR in this mouse model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Tomas</LastName><ForeName>Doris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>McLeod</LastName><ForeName>Victoria M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiam</LastName><ForeName>Mathew D F</ForeName><Initials>MDF</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanniarachchillage</LastName><ForeName>Nayomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boon</LastName><ForeName>Wah C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Bradley J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Florey Institute of Neuroscience and Mental Health, University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia. bradley.turner@florey.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perron Institute for Neurological and Translational Science, Queen Elizabeth Medical Centre, Nedlands, WA, 6150, Australia. bradley.turner@florey.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C410798">AR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33927243</ArticleId><ArticleId IdType="pmc">PMC8085012</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-88415-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-88415-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend. Med. 2010;7:557&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, et al. C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:281.</Citation><ArticleIdList><ArticleId IdType="pubmed">27663272</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, et al. Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: The effect of male sex on survival of C9orf72 positive patients. Front. Neurosci. 2019;13:485. doi: 10.3389/fnins.2019.00485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00485</ArticleId><ArticleId IdType="pmc">PMC6534038</ArticleId><ArticleId IdType="pubmed">31156370</ArticleId></ArticleIdList></Reference><Reference><Citation>Blecher R, et al. Contact sports as a risk factor for amyotrophic lateral sclerosis: A systematic review. Global Spine J. 2019;9:104&#x2013;118. doi: 10.1177/2192568218813916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568218813916</ArticleId><ArticleId IdType="pmc">PMC6362556</ArticleId><ArticleId IdType="pubmed">30775214</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59:773&#x2013;775. doi: 10.1212/WNL.59.5.773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.5.773</ArticleId><ArticleId IdType="pubmed">12221178</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser AE, et al. Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2018;89:797&#x2013;803. doi: 10.1136/jnnp-2017-317724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317724</ArticleId><ArticleId IdType="pubmed">29685899</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E. Are professional soccer players at higher risk for ALS? Amyotroph. Lateral Scler. Frontotemp. Degener. 2013;14:501&#x2013;506. doi: 10.3109/21678421.2013.809764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.809764</ArticleId><ArticleId IdType="pubmed">23859483</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivekananda U, et al. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J. Neurol. Neurosurg. Psychiatry. 2011;82:635&#x2013;637. doi: 10.1136/jnnp.2010.220012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.220012</ArticleId><ArticleId IdType="pubmed">21551173</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning JT, Morris L, Caswell N. Endurance running and digit ratio (2D:4D): Implications for fetal testosterone effects on running speed and vascular health. Am. J. Hum. Biol. 2007;19:416&#x2013;421. doi: 10.1002/ajhb.20603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajhb.20603</ArticleId><ArticleId IdType="pubmed">17420996</ArticleId></ArticleIdList></Reference><Reference><Citation>Giffin NA, Kennedy RM, Jones ME, Barber CA. Varsity athletes have lower 2D:4D ratios than other university students. J. Sports Sci. 2012;30:135&#x2013;138. doi: 10.1080/02640414.2011.630744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02640414.2011.630744</ArticleId><ArticleId IdType="pubmed">22132823</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl SR, Halicek MT, Mitchell CS. Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: A meta-analysis. J. Neuromuscul. Dis. 2015;2:137&#x2013;150. doi: 10.3233/JND-140068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-140068</ArticleId><ArticleId IdType="pmc">PMC4652798</ArticleId><ArticleId IdType="pubmed">26594635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T, et al. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 2014;1584:59&#x2013;72. doi: 10.1016/j.brainres.2013.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.10.013</ArticleId><ArticleId IdType="pubmed">24141148</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 2008;85:94&#x2013;134. doi: 10.1016/j.pneurobio.2008.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheean RK, et al. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice. J. Neuroinflamm. 2015;12:40. doi: 10.1186/s12974-015-0254-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0254-3</ArticleId><ArticleId IdType="pmc">PMC4359394</ArticleId><ArticleId IdType="pubmed">25889790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes-Punzo A, et al. Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:311&#x2013;314. doi: 10.3109/17482968.2012.654393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.654393</ArticleId><ArticleId IdType="pmc">PMC3644484</ArticleId><ArticleId IdType="pubmed">22409357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostaghel EA, et al. Contribution of adrenal glands to intratumor androgens and growth of castration-resistant prostate cancer. Clin. Cancer Res. 2019;25:426&#x2013;439. doi: 10.1158/1078-0432.CCR-18-1431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-18-1431</ArticleId><ArticleId IdType="pmc">PMC6320302</ArticleId><ArticleId IdType="pubmed">30181386</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod VM, et al. Androgen receptor antagonism accelerates disease onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Br. J. Pharmacol. 2019;176:2111&#x2013;2130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6555856</ArticleId><ArticleId IdType="pubmed">30849180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YE, Ko CP. Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS ONE. 2012;7:e37258. doi: 10.1371/journal.pone.0037258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037258</ArticleId><ArticleId IdType="pmc">PMC3351454</ArticleId><ArticleId IdType="pubmed">22606355</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal T, et al. Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:1929&#x2013;1938. doi: 10.1016/j.neurobiolaging.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.02.004</ArticleId><ArticleId IdType="pubmed">24630363</ArticleId></ArticleIdList></Reference><Reference><Citation>Tronche F, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 1999;23:99&#x2013;103. doi: 10.1038/12703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/12703</ArticleId><ArticleId IdType="pubmed">10471508</ArticleId></ArticleIdList></Reference><Reference><Citation>Raskin K, et al. Conditional inactivation of androgen receptor gene in the nervous system: Effects on male behavioral and neuroendocrine responses. J. Neurosci. 2009;29:4461&#x2013;4470. doi: 10.1523/JNEUROSCI.0296-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0296-09.2009</ArticleId><ArticleId IdType="pmc">PMC6665718</ArticleId><ArticleId IdType="pubmed">19357272</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey RA, et al. Androgen action via the androgen receptor in neurons within the brain positively regulates muscle mass in male mice. Endocrinology. 2017;158:3684&#x2013;3695. doi: 10.1210/en.2017-00470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2017-00470</ArticleId><ArticleId IdType="pubmed">28977603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty P, et al. Androgen-dependent sertoli cell tight junction remodeling is mediated by multiple tight junction components. Mol. Endocrinol. 2014;28:1055&#x2013;1072. doi: 10.1210/me.2013-1134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2013-1134</ArticleId><ArticleId IdType="pmc">PMC4075161</ArticleId><ArticleId IdType="pubmed">24825397</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdcraft RW, Braun RE. Androgen receptor function is required in Sertoli cells for the terminal differentiation of haploid spermatids. Development. 2004;131:459&#x2013;467. doi: 10.1242/dev.00957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.00957</ArticleId><ArticleId IdType="pubmed">14701682</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean HE, et al. A floxed allele of the androgen receptor gene causes hyperandrogenization in male mice. Physiol. Genomics. 2008;33:133&#x2013;137. doi: 10.1152/physiolgenomics.00260.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00260.2007</ArticleId><ArticleId IdType="pubmed">18171720</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;854. doi: 10.1016/S0896-6273(02)00834-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00834-6</ArticleId><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Galichet C, Lovell-Badge R, Rizzoti K. Nestin-Cre mice are affected by hypopituitarism, which is not due to significant activity of the transgene in the pituitary gland. PLoS ONE. 2010;5:e11443. doi: 10.1371/journal.pone.0011443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011443</ArticleId><ArticleId IdType="pmc">PMC2897851</ArticleId><ArticleId IdType="pubmed">20625432</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod, V.M., et al. Dysregulation of steroid hormone receptors in motor neurons and glia associates with disease progression in ALS mice. Endocrinology161(2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32621747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, et al. Identification of androgen response elements in the insulin-like growth factor I upstream promoter. Endocrinology. 2007;148:2984&#x2013;2993. doi: 10.1210/en.2006-1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2006-1653</ArticleId><ArticleId IdType="pubmed">17363459</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida, T. &amp; Delafontaine, P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells9 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7564605</ArticleId><ArticleId IdType="pubmed">32858949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science. 2003;301:839&#x2013;842. doi: 10.1126/science.1086137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086137</ArticleId><ArticleId IdType="pubmed">12907804</ArticleId></ArticleIdList></Reference><Reference><Citation>Juntti SA, et al. The androgen receptor governs the execution, but not programming, of male sexual and territorial behaviors. Neuron. 2010;66:260&#x2013;272. doi: 10.1016/j.neuron.2010.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.03.024</ArticleId><ArticleId IdType="pmc">PMC2923659</ArticleId><ArticleId IdType="pubmed">20435002</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois NC, Hofmann D, Kaloulis K, Bishop JM, Trumpp A. Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues. Genesis. 2006;44:355&#x2013;360. doi: 10.1002/dvg.20226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvg.20226</ArticleId><ArticleId IdType="pubmed">16847871</ArticleId></ArticleIdList></Reference><Reference><Citation>Harno E, Cottrell EC, White A. Metabolic pitfalls of CNS Cre-based technology. Cell Metab. 2013;18:21&#x2013;28. doi: 10.1016/j.cmet.2013.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.05.019</ArticleId><ArticleId IdType="pubmed">23823475</ArticleId></ArticleIdList></Reference><Reference><Citation>Ophoff J, et al. Androgen signaling in myocytes contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. Endocrinology. 2009;150:3558&#x2013;3566. doi: 10.1210/en.2008-1509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2008-1509</ArticleId><ArticleId IdType="pubmed">19264874</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambon C, et al. Myocytic androgen receptor controls the strength but not the mass of limb muscles. Proc. Natl. Acad. Sci. U S A. 2010;107:14327&#x2013;14332. doi: 10.1073/pnas.1009536107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009536107</ArticleId><ArticleId IdType="pmc">PMC2922552</ArticleId><ArticleId IdType="pubmed">20660752</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl. Acad. Sci. U S A. 2007;104:18259&#x2013;18264. doi: 10.1073/pnas.0705501104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705501104</ArticleId><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee AJ, Gunning PW, Hardeman EC. Diverse roles of the actin cytoskeleton in striated muscle. J. Muscle Res. Cell Motil. 2009;30:187&#x2013;197. doi: 10.1007/s10974-009-9193-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10974-009-9193-x</ArticleId><ArticleId IdType="pubmed">19997772</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Loeffler JP. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr. Opin. Pharmacol. 2009;9:341&#x2013;346. doi: 10.1016/j.coph.2009.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2009.03.007</ArticleId><ArticleId IdType="pubmed">19386549</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, et al. Both endogenous and exogenous testosterone decrease myocardial STAT3 activation and SOCS3 expression after acute ischemia and reperfusion. Surgery. 2009;146:138&#x2013;144. doi: 10.1016/j.surg.2009.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2009.03.035</ArticleId><ArticleId IdType="pmc">PMC2771912</ArticleId><ArticleId IdType="pubmed">19628067</ArticleId></ArticleIdList></Reference><Reference><Citation>Verzola D, et al. Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase. Biochem. Biophys. Res. Commun. 2009;387:531&#x2013;536. doi: 10.1016/j.bbrc.2009.07.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.07.056</ArticleId><ArticleId IdType="pubmed">19615976</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeap, B.B., Dwivedi, G., Chih, H.J. &amp; Reid, C. Androgens and cardiovascular disease in men. In Endotext (eds. Feingold, K.R., et al.) (South Dartmouth, 2000).</Citation></Reference><Reference><Citation>Chang C, Yeh S, Lee SO, Chang TM. Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: Lessons learned from mice lacking AR in specific cells. Nucl. Recept. Signal. 2013;11:e001. doi: 10.1621/nrs.11001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1621/nrs.11001</ArticleId><ArticleId IdType="pmc">PMC3960937</ArticleId><ArticleId IdType="pubmed">24653668</ArticleId></ArticleIdList></Reference><Reference><Citation>Forgie ML, Kolb B. Manipulation of gonadal hormones in neonatal rats alters the morphological response of cortical neurons to brain injury in adulthood. Behav. Neurosci. 2003;117:257&#x2013;262. doi: 10.1037/0735-7044.117.2.257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0735-7044.117.2.257</ArticleId><ArticleId IdType="pubmed">12708522</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisz J, Ward IL. Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology. 1980;106:306&#x2013;316. doi: 10.1210/endo-106-1-306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo-106-1-306</ArticleId><ArticleId IdType="pubmed">7349961</ArticleId></ArticleIdList></Reference><Reference><Citation>Swift-Gallant A, Coome LA, Ramzan F, Monks DA. Nonneural androgen receptors affect sexual differentiation of brain and behavior. Endocrinology. 2016;157:788&#x2013;798. doi: 10.1210/en.2015-1355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2015-1355</ArticleId><ArticleId IdType="pubmed">26636184</ArticleId></ArticleIdList></Reference><Reference><Citation>Heitzer M, et al. Administration of 17beta-estradiol improves motoneuron survival and down-regulates inflammasome activation in male SOD1(G93A) ALS mice. Mol. Neurobiol. 2017;54:8429&#x2013;8443. doi: 10.1007/s12035-016-0322-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0322-4</ArticleId><ArticleId IdType="pubmed">27957680</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kim TY, Cho KS, Kim HN, Koh JY. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;59:80&#x2013;85. doi: 10.1016/j.nbd.2013.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.07.011</ArticleId><ArticleId IdType="pubmed">23891729</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld GJ, et al. Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. Brain Res. 2004;1021:128&#x2013;131. doi: 10.1016/j.brainres.2004.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.06.024</ArticleId><ArticleId IdType="pubmed">15328040</ArticleId></ArticleIdList></Reference><Reference><Citation>Snell DM, Turner JMA. Sex chromosome effects on male-female differences in mammals. Curr. Biol. 2018;28:R1313&#x2013;R1324. doi: 10.1016/j.cub.2018.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.09.018</ArticleId><ArticleId IdType="pmc">PMC6264392</ArticleId><ArticleId IdType="pubmed">30458153</ArticleId></ArticleIdList></Reference><Reference><Citation>Voskuhl RR, Sawalha AH, Itoh Y. Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression. Mult. Scler. 2018;24:22&#x2013;31. doi: 10.1177/1352458517737394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458517737394</ArticleId><ArticleId IdType="pmc">PMC5823689</ArticleId><ArticleId IdType="pubmed">29307297</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden, L.C., et al. Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes. Proc. Natl. Acad. Sci. U S A (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6936674</ArticleId><ArticleId IdType="pubmed">31822606</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, et al. Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson's disease. Proc. Natl. Acad. Sci. U S A. 2019;116:16577&#x2013;16582. doi: 10.1073/pnas.1900406116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1900406116</ArticleId><ArticleId IdType="pmc">PMC6697880</ArticleId><ArticleId IdType="pubmed">31371505</ArticleId></ArticleIdList></Reference><Reference><Citation>Declercq J, et al. Metabolic and behavioural phenotypes in nestin-cre mice are caused by hypothalamic expression of human growth hormone. PLoS ONE. 2015;10:e0135502. doi: 10.1371/journal.pone.0135502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135502</ArticleId><ArticleId IdType="pmc">PMC4537087</ArticleId><ArticleId IdType="pubmed">26275221</ArticleId></ArticleIdList></Reference><Reference><Citation>Briancon N, McNay DE, Maratos-Flier E, Flier JS. Combined neural inactivation of suppressor of cytokine signaling-3 and protein-tyrosine phosphatase-1B reveals additive, synergistic, and factor-specific roles in the regulation of body energy balance. Diabetes. 2010;59:3074&#x2013;3084. doi: 10.2337/db10-0481.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-0481</ArticleId><ArticleId IdType="pmc">PMC2992768</ArticleId><ArticleId IdType="pubmed">20876718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol. Rev. 2014;94:355&#x2013;382. doi: 10.1152/physrev.00030.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00030.2013</ArticleId><ArticleId IdType="pmc">PMC4044302</ArticleId><ArticleId IdType="pubmed">24692351</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, et al. Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis. Endocrinology. 2012;153:3735&#x2013;3746. doi: 10.1210/en.2011-2171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2011-2171</ArticleId><ArticleId IdType="pubmed">22621959</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharaoh G, et al. Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice. Front. Neurosci. 2019;13:487. doi: 10.3389/fnins.2019.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00487</ArticleId><ArticleId IdType="pmc">PMC6554287</ArticleId><ArticleId IdType="pubmed">31213966</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza, S., et al. Skeletal-muscle metabolic reprogramming in ALS-SOD1(G93A) mice predates disease onset and is a promising therapeutic target. iScience23, 101087 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200935</ArticleId><ArticleId IdType="pubmed">32371370</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, et al. Growth hormone secretion is correlated with neuromuscular innervation rather than motor neuron number in early-symptomatic male amyotrophic lateral sclerosis mice. Endocrinology. 2013;154:4695&#x2013;4706. doi: 10.1210/en.2013-1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2013-1570</ArticleId><ArticleId IdType="pubmed">24108071</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J. Clin. Invest. 1990;86:1423&#x2013;1427. doi: 10.1172/JCI114857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI114857</ArticleId><ArticleId IdType="pmc">PMC296885</ArticleId><ArticleId IdType="pubmed">2243122</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid Res. 2007;48:1571&#x2013;1580. doi: 10.1194/jlr.M700017-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M700017-JLR200</ArticleId><ArticleId IdType="pmc">PMC1974855</ArticleId><ArticleId IdType="pubmed">17438338</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, et al. A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1. Mol. Neurodegener. 2011;6:26. doi: 10.1186/1750-1326-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-26</ArticleId><ArticleId IdType="pmc">PMC3111394</ArticleId><ArticleId IdType="pubmed">21521523</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald, T.S., Kumar, V., Fung, J.N., Woodruff, T.M. &amp; Lee, J.D. Glucose clearance and uptake is increased in the SOD1&lt;sub&gt;G93A&lt;/sub&gt; mouse model of amyotrophic lateral sclerosis through an insulin-independent mechanism. bioRxiv:2020.2008.2002.233411 (2020).</Citation></Reference><Reference><Citation>McLeod, V.M., Cuic, B., Chiam, M.D.F., Lau, C.L. &amp; Turner, B.J. Exploring germline recombination in Nestin-Cre transgenic mice using floxed androgen receptor. Genesis, e23390 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32744751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>